Literature DB >> 25126166

FRAS1 knockdown reduces A549 cells migration and invasion through downregulation of FAK signaling.

Qiong Zhan1, Ruo-Fan Huang1, Xiao-Hua Liang1, Meng-Xi Ge1, Jing-Wei Jiang1, Hao Lin2, Xin-Li Zhou1.   

Abstract

Distal metastasis is the major cause of death for the vast majority of lung cancer patients. Many extracellular matrix (ECM)-related molecules are proposed to be associated with the migration and invasion of cancer cells. FRAS1 encodes an ECM protein, however, little is known about its function on tumorigenesis and metastasis of lung cancer. In this work, FRAS1 was silenced by shRNA in non-small cell lung cancer (NSCLC) A549 cell line. The capacities of A549 cells to migrate and invade were decreased markedly after FRAS1 knockdown. The shRNA knockdown of FRAS1 was found to be specific and had no effect on A549 cells proliferation. Western blot experiments demonstrated that FRAS1 knockdown inhibited FAK signaling but not Src signaling. Overall, we found that FRAS1 knockdown reduces A549 cells migration and invasion ability through downregulation of FAK signaling.

Entities:  

Keywords:  FAK signaling; FRAS1; Lung cancer metastasis; migration and invasion

Year:  2014        PMID: 25126166      PMCID: PMC4132130     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  23 in total

1.  Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling.

Authors:  I G Kim; S Y Kim; S I Choi; J H Lee; K C Kim; E W Cho
Journal:  Oncogene       Date:  2013-09-09       Impact factor: 9.867

Review 2.  Integrin-regulated FAK-Src signaling in normal and cancer cells.

Authors:  Satyajit K Mitra; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2006-08-17       Impact factor: 8.382

3.  Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA.

Authors:  Simon Toupance; Bertrand Brassart; Fanja Rabenoelina; Christelle Ghoneim; Laurent Vallar; Myriam Polette; Laurent Debelle; Philippe Birembaut
Journal:  Clin Exp Metastasis       Date:  2012-03-21       Impact factor: 5.150

4.  NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells.

Authors:  S Yoon; S U Woo; J H Kang; K Kim; H-J Shin; H-S Gwak; S Park; Y-J Chwae
Journal:  Oncogene       Date:  2011-11-21       Impact factor: 9.867

Review 5.  Progress in researches about focal adhesion kinase in gastrointestinal tract.

Authors:  Hui-Fang Hao; Yoshio Naomoto; Xiao-Hong Bao; Nobuyuki Watanabe; Kazufumi Sakurama; Kazuhiro Noma; Yasuko Tomono; Takuya Fukazawa; Yasuhiro Shirakawa; Tomoki Yamatsuji; Junji Matsuoka; Munenori Takaoka
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

6.  Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion.

Authors:  Deshui Jia; Mingxia Yan; Xiaomin Wang; Xiangfang Hao; Linhui Liang; Lei Liu; Hanwei Kong; Xianghuo He; Jinjun Li; Ming Yao
Journal:  BMC Cancer       Date:  2010-07-09       Impact factor: 4.430

7.  Fraser syndrome and mouse blebbed phenotype caused by mutations in FRAS1/Fras1 encoding a putative extracellular matrix protein.

Authors:  Lesley McGregor; Ville Makela; Susan M Darling; Sofia Vrontou; Georges Chalepakis; Catherine Roberts; Nicola Smart; Paul Rutland; Natalie Prescott; Jason Hopkins; Elizabeth Bentley; Alison Shaw; Emma Roberts; Robert Mueller; Shalini Jadeja; Nicole Philip; John Nelson; Christine Francannet; Antonio Perez-Aytes; Andre Megarbane; Bronwyn Kerr; Brandon Wainwright; Adrian S Woolf; Robin M Winter; Peter J Scambler
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

8.  Assessment of the anti-invasion potential and mechanism of select cinnamic acid derivatives on human lung adenocarcinoma cells.

Authors:  Chiung-Man Tsai; Gow-Chin Yen; Fang-Ming Sun; Shun-Fa Yang; Chia-Jui Weng
Journal:  Mol Pharm       Date:  2013-04-19       Impact factor: 4.939

9.  PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.

Authors:  Yong Luo; Fubo Liang; Zhong-Yin Zhang
Journal:  Biochemistry       Date:  2009-03-03       Impact factor: 3.162

10.  Prognostic significance of CD44s expression in resected non-small cell lung cancer.

Authors:  Yoon Ho Ko; Hye Sung Won; Eun Kyoung Jeon; Sook Hee Hong; Sang Young Roh; Young Seon Hong; Jae Ho Byun; Chan-Kwon Jung; Jin Hyoung Kang
Journal:  BMC Cancer       Date:  2011-08-07       Impact factor: 4.430

View more
  12 in total

1.  MicroRNA-7 inhibits metastasis and invasion through targeting focal adhesion kinase in cervical cancer.

Authors:  Zhenfeng Hao; Jishi Yang; Chenghai Wang; Yaoyao Li; Yu Zhang; Xiaoyun Dong; Liulin Zhou; Jing Liu; Yanqing Zhang; Jing Qian
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Suppression of chronic lymphocytic leukemia progression by CXCR4 inhibitor WZ811.

Authors:  Shi Hui Li; Wen Chuan Dong; Li Fan; Guang Sheng Wang
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

3.  Methylation silencing of ULK2 via epithelial-mesenchymal transition causes transformation to poorly differentiated gastric cancers.

Authors:  Iori Motoo; Sohachi Nanjo; Takayuki Ando; Satoshi Yamashita; Toshikazu Ushijima; Ichiro Yasuda
Journal:  Gastric Cancer       Date:  2021-09-23       Impact factor: 7.370

4.  SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population.

Authors:  Qiufen Xie; Yuan Li; Zhiyan Liu; Guangyan Mu; Hanxu Zhang; Shuang Zhou; Zhe Wang; Zining Wang; Jie Jiang; Xin Li; Qian Xiang; Yimin Cui
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

5.  A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.

Authors:  Victoria Wang; Milan S Geybels; Kristina M Jordahl; Travis Gerke; Anis Hamid; Kathryn L Penney; Sarah C Markt; Matthew Freedman; Mark Pomerantz; Gwo-Shu M Lee; Huma Rana; Daniela Börnigen; Timothy R Rebbeck; Curtis Huttenhower; Ros A Eeles; Janet L Stanford; Practical Consortium; Sonja I Berndt; Frank Claessens; Karina D Sørensen; Jong Y Park; Ana Vega; Nawaid Usmani; Lorelei Mucci; Christopher J Sweeney
Journal:  Prostate       Date:  2021-05-06       Impact factor: 4.012

6.  Elucidating mechanisms of sunitinib resistance in renal cancer: an integrated pathological-molecular analysis.

Authors:  Henriett Butz; Qiang Ding; Roy Nofech-Mozes; Zsuzsanna Lichner; Heyu Ni; George M Yousef
Journal:  Oncotarget       Date:  2017-12-08

7.  Computational/experimental evaluation of liver metastasis post hepatic injury: interactions with macrophages and transitional ECM.

Authors:  Shanice V Hudson; Hunter A Miller; Grace E Mahlbacher; Douglas Saforo; Levi J Beverly; Gavin E Arteel; Hermann B Frieboes
Journal:  Sci Rep       Date:  2019-10-21       Impact factor: 4.379

8.  Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.

Authors:  Brooke L Fridley; Taraswi M Ghosh; Alice Wang; Rama Raghavan; Junqiang Dai; Ellen L Goode; Jatinder K Lamba
Journal:  Front Genet       Date:  2016-03-22       Impact factor: 4.599

9.  Circular RNA profiling identifies circ102049 as a key regulator of colorectal liver metastasis.

Authors:  Qiaoming Zhi; Daiwei Wan; Rui Ren; Zhihua Xu; Xiaobo Guo; Ye Han; Fei Liu; Ye Xu; Lei Qin; Yilin Wang
Journal:  Mol Oncol       Date:  2020-12-29       Impact factor: 7.449

10.  Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.

Authors:  Han-Ning Li; Xing-Rui Li; Zheng-Tao Lv; Miao-Miao Cai; Ge Wang; Zhi-Fang Yang
Journal:  Cancer Med       Date:  2020-10-14       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.